Updates: Update - Page 2
Thought Leadership Workshop hosted by NB: Emerging in vitro technologies for gene therapy applications
These include the first oligonucleotide-based therapies (Spinraza, Exondys, Vyondys), in vivo gene therapies (Luxturna and Zolgensma) and the first cell therapies (Kymriah, Yescarta, Tescartus). Such novel therapeutics treat disorders varying…
Read update
Our commitment to the 3Rs
There are few topics more controversial than the use of animals in science, despite the enormous contribution animal experimentation continues to make to the development of new medicines and…
Read update
Covid-19 action plan – 2021 update
In line with our previous Covid-19 Action Plan, Newcells Biotech has continued to review and invest in measures to reduce the risk to its staff and…
Read update
An overview of vaccine development & sub-types
Vaccination can be regarded as one of biomedicines biggest triumphs. Since Edward Jenner pioneered the smallpox vaccine in 1798, subsequent morbidity and mortality rates have
Read update
The Human Cell Atlas – an aid to understanding COVID-19 & a valuable tool in the development of hiPSC models
The outbreak of the novel viral disease, COVID-19, caused by the severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has led to worldwide health and economic catastrophe.1 Almost 2 million…
Read update
Covid-19 action plan – A message to our customers, collaboration partners & colleagues
As we all come to terms with the extraordinary and rapidly changing global situation caused by Covid-19, I would like to update you on the plans we have in…
Read update
Newcells Biotech technology: the fight against antibacterial resistance
Antibacterial resistance is an ever-increasing concern for today’s society. As more bacterial strains become resistant to greater numbers of antibiotics, we could see modern-day healthcare rewind back to the…
Read update
WHO WE ARE
A passionate, rigorous and dedicated team of scientists who deliver the highest quality services and products. Your reliable and knowledgeable partner.
Read updateWHAT WE DO
Learning from structures in the body, we recreate functional 3D in vitro models through innovation and science. Our models incorporate the “best biology” and are predictive of new drugs’…
Read updateHOW WE DO IT
Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung. We engineer…
Read updateWHY WE DO IT
Our purpose is to bridge the gap between scientific discovery and patients. We make a difference by providing better predictions of clinical outcomes.
Read update
Looking forward: A year in review
2018 has been a significant year for Newcells Biotech. We have secured substantial investment, launched new, ground-breaking products, attended global events and expanded our every growing team. Here are some of…
Read update
